Sorrento Therapeutics (NASDAQ:SRNE) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.00 on Thursday. Sorrento Therapeutics has a 52 week low of […]

Leave a Reply

Your email address will not be published.

Previous post H.B. Fuller Issues Preliminary Financial Information for the Year Ended November 30, 2024
Next post Flexible Solutions International (NYSE:FSI) Earns Hold Rating from Analysts at StockNews.com